Literature DB >> 10464279

alpha-synuclein binds to Tau and stimulates the protein kinase A-catalyzed tau phosphorylation of serine residues 262 and 356.

P H Jensen1, H Hager, M S Nielsen, P Hojrup, J Gliemann, R Jakes.   

Abstract

alpha-Synuclein has been implicated in the pathogenesis of several neurodegenerative disorders based on the direct linking of missense mutations in alpha-synuclein to autosomal dominant Parkinson's disease and its presence in Lewy-like lesions. To gain insight into alpha-synuclein functions, we have investigated whether it binds neuronal proteins and modulates their functional state. The microtubule-associated protein tau was identified as a ligand by alpha-synuclein affinity chromatography of human brain cytosol. Direct binding assays using (125)I-labeled human tau40 demonstrated a reversible binding with a IC(50) about 50 pM. The interacting domains were localized to the C terminus of alpha-synuclein and the microtubule binding region of tau as determined by protein fragmentation and the use of recombinant peptides. High concentrations of tubulin inhibited the binding between tau and alpha-synuclein. Functionally, alpha-synuclein stimulated the protein kinase A-catalyzed phosphorylation of tau serine residues 262 and 356 as determined using a phospho-epitope-specific antibody. We propose that alpha-synuclein modulates the phosphorylation of soluble axonal tau and thereby indirectly affects the stability of axonal microtubules.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10464279     DOI: 10.1074/jbc.274.36.25481

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  114 in total

1.  Quantitative proteomics identifies surfactant-resistant alpha-synuclein in cerebral cortex of Parkinsonism-dementia complex of Guam but not Alzheimer's disease or progressive supranuclear palsy.

Authors:  Wan Yang; Randall L Woltjer; Izabela Sokal; Catherine Pan; Yan Wang; Mary Brodey; Elaine R Peskind; James B Leverenz; Jing Zhang; Daniel P Perl; Douglas R Galasko; Thomas J Montine
Journal:  Am J Pathol       Date:  2007-08-03       Impact factor: 4.307

2.  Secondary structure and dynamics of micelle bound beta- and gamma-synuclein.

Authors:  Yoon-Hui Sung; David Eliezer
Journal:  Protein Sci       Date:  2006-04-05       Impact factor: 6.725

3.  Allostery in a disordered protein: oxidative modifications to α-synuclein act distally to regulate membrane binding.

Authors:  Eva Sevcsik; Adam J Trexler; Joanna M Dunn; Elizabeth Rhoades
Journal:  J Am Chem Soc       Date:  2011-04-14       Impact factor: 15.419

Review 4.  Neuroproteomics as a promising tool in Parkinson's disease research.

Authors:  Ilse S Pienaar; William M U Daniels; Jürgen Götz
Journal:  J Neural Transm (Vienna)       Date:  2008-06-04       Impact factor: 3.575

5.  Proteasome inhibition leads to early loss of synaptic proteins in neuronal culture.

Authors:  Natasha Bajic; Peter Jenner; Clive G Ballard; Paul T Francis
Journal:  J Neural Transm (Vienna)       Date:  2012-05-17       Impact factor: 3.575

6.  Co-localization of tau and alpha-synuclein in the olfactory bulb in Alzheimer's disease with amygdala Lewy bodies.

Authors:  Hiroshige Fujishiro; Yoshio Tsuboi; Wen-Lang Lin; Hirotake Uchikado; Dennis W Dickson
Journal:  Acta Neuropathol       Date:  2008-04-30       Impact factor: 17.088

7.  RNA interference mediated silencing of alpha-synuclein in MN9D cells and its effects on cell viability.

Authors:  Dong-Mei Liu; Ling Jin; Hao Wang; Huan-Ying Zhao; Chun-Li Zhao; Hui Yang
Journal:  Neurosci Bull       Date:  2008-04       Impact factor: 5.203

8.  Pleiotropic neuropathological and biochemical alterations associated with Myo5a mutation in a rat Model.

Authors:  Kerstin K Landrock; Patti Sullivan; Heidi Martini-Stoica; David S Goldstein; Brett H Graham; Shinya Yamamoto; Hugo J Bellen; Richard A Gibbs; Rui Chen; Marcello D'Amelio; George Stoica
Journal:  Brain Res       Date:  2017-12-05       Impact factor: 3.252

9.  Untangling a role for tau in synucleinopathies.

Authors:  Marion Delenclos; Simon Moussaud; Pamela J McLean
Journal:  Biol Psychiatry       Date:  2015-11-15       Impact factor: 13.382

Review 10.  Neurobiology of alpha-synuclein.

Authors:  Kostas Vekrellis; Hardy J Rideout; Leonidas Stefanis
Journal:  Mol Neurobiol       Date:  2004-08       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.